GPAT · GP-Act III Acquisition Corp.

GP-Act III Acquisition Corp. convened its extraordinary general meeting on April 29, 2026, where shareholders voted to approve the adjournment of the meeting rather than the substantive business combination extension proposals themselves. The Adjournment Proposal passed with significant support, receiving 21.3 million votes in favor versus 8.0 million against. The purpose of the adjournment is to permit further solicitation of proxies regarding the Extension Amendment Proposal and the Trust Amendment Proposal, which aim to extend the deadline for the company to complete a business combination from May 13, 2026, to November 13, 2026. The meeting is scheduled to reconvene on May 6, 2026. In conjunction with the adjournment, the company has implemented a provision allowing shareholders who previously elected to redeem their public Class A ordinary shares to reverse those redemption requests. This reversal option is available until 9:00 a.m. Eastern Time on May 6, 2026, providing shareholders an opportunity to reconsider their position in light of the proposed extension. The record date for the meeting was March 24, 2026, with 35,937,500 ordinary shares outstanding.